Geptanolimab
Product Specifications
CAS Number
2348469-43-0
Target
PD-1/PD-L1
Related Pathways
Apoptosis, Cell Cycle/Checkpoint, Immunology/Inflammation
Purity
0.995
Bioactivity
Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1) . Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
